Methotrexate Sodium

CAS 15475-77-1 5 API suppliersSmall Molecule

Overview

Methotrexate sodium is a folate analog metabolic inhibitor that exerts its antineoplastic and immunosuppressive properties by inhibiting the enzyme dihydrofolate reductase, interfering with DNA synthesis, repair, and cellular replication. It is used in the treatment of various types of cancer and autoimmune diseases such as rheumatoid arthritis.

API suppliers (5)

Suppliers of Methotrexate Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India3Germany1

Country recorded for 4 of 5 suppliers.

2 of 5 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

OncologyRheumatologyDermatology
Verified Supplier Partner

Do you supply Methotrexate Sodium? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.